In a filing, BIOLASE Inc. revealed its Director LORD JONATHAN T MD unloaded Company’s shares for reported $2653.0 on Dec 07. In the deal valued at $0.75 per share,3,537 shares were sold. As a result of this transaction, LORD JONATHAN T MD now holds 59,925 shares worth roughly $ 0.25 million.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
The Benchmark Company initiated its BIOLASE Inc. [BIOL] rating to a Speculative buy in a research note published on Friday, June 19, 2019; the price target was $2. PT values the company’s stock at a premium of -104.5 to its Friday closing price.
Price Performance Review of BIOL
On Friday, BIOLASE Inc. [NASDAQ:BIOL] saw its stock fall -6.41% to $4.09. On the same session, the stock had its day’s lowest price of $4.03, but rose to a high of $4.5299. Over the last five days, the stock has lost -17.04%. BIOLASE Inc. shares have fallen nearly -93.71% since the year began. Nevertheless, the stocks have fallen -98.94% over the past one year. While a 52-week high of $390.00 was reached on 01/09/23, a 52-week low of $4.19 was recorded on 09/01/23. SMA at 50 days reached $6.64, while 200 days put it at $36.47. A total of 59285.0 shares were traded, compared to the trading of 76800.0 shares in the previous session.
Levels Of Support And Resistance For BIOL Stock
The 24-hour chart illustrates a support level at 3.90, which if violated will result in even more drops to 3.72. On the upside, there is a resistance level at 4.40. A further resistance level may holdings at 4.72. The Relative Strength Index (RSI) on the 14-day chart is 30.88, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.82, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 97.75%. Stochastics %K at 3.80% indicates the stock is a buying.
How much short interest is there in BIOLASE Inc.?
A steep rise in short interest was recorded in BIOLASE Inc. stocks on Aug 14, 2023, growing by 0.12 million shares to a total of 0.15 million shares. Yahoo Finance data shows the prior-month short interest on Jul 13, 2023 was 31090.0 shares. There was a rise of 79.82%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 14.79% of the overall stock float, the days-to-cover ratio (short ratio) rose to 0.39.
BIOLASE Inc. [BIOL] – Who Are The Largest Shareholders?
In filings from Walleye Capital LLC, it is revealed that the company now owns 14,205 shares, or roughly 1.36% of the outstanding BIOL shares.. At present, Two Sigma Securities LLC is holding 1,609 shares valued at $9799.0. Perkins Capital Management, Inc. owned 1,572 shares of the company at the time of its most recent 13F filing, worth $9573.0.
According to FactSet, BIOLASE Inc.’s share price will average $36.67 in the next year, based on opinions of analysts polled by the firm. This is up nearly 815.33 percent from its previous closing price of $4.37. Analysts expect BIOLASE Inc. stock to reach the higher price of $40.00, while the lowest price estimate is $30.00. However, 3 analysts have rated BIOL stock as a Buy in their predictions for 2023.